Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 overexpression and mutation, chemoresistance and patient survival in oral and maxillofacial squamous cell carcinoma.

Journal of chemotherapy (Florence, Italy) - 1 Apr 1997

Cutilli T, Papola F, Corbacelli A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Cisplatin

Share to Fluorouracil

Share to Mouth Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 9176754
DOI: 10.1179/joc.1997.9.2.123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 overexpression and mutation, chemoresistance and patient survival in oral and maxillofacial squamous cell carcinoma.PMID 9176754Read ↗

TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.Semantic proximity Read ↗

[p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].Semantic proximity Read ↗

Targeting the DNA Damage Response in OSCC with TP53 Mutations.Semantic proximity Read ↗

TP53 and head and neck neoplasms.Semantic proximity Read ↗

p53 overexpression in head and neck squamous cell carcinoma: review of the literature.Semantic proximity Read ↗

p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation.Semantic proximity Read ↗

[p53 mutations and chemoresistance in oromaxillofacial squamous-cell carcinomas. The results of a molecular genetics study of p53 in metastatic oromaxillofacial tumors and an evaluation of the response to neoadjuvant chemotherapeutic treatment].Semantic proximity Read ↗

Frequency of p53 gene mutation and protein expression in oral squamous cell carcinoma.Semantic proximity Read ↗

Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.Semantic proximity Read ↗

[p53 mutation and chemoresistance in oral-maxillofacial squamous cell carcinoma. Role of p53 in the cell cycle control and in the modulating action of chemotherapeutic agents].Semantic proximity Read ↗

p53 in hematologic malignancies.Semantic proximity Read ↗

Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.